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Abstract
BACKGROUND—The shape of human red blood cells (RBCs) deteriorates progressively 
throughout hypothermic storage, with echinocytosis being the most prevalent pathway of this 
morphological lesion. As a result, each unit of stored blood contains a heterogeneous mixture of 
cells in various stages of echinocytosis and normal discocytes. Here we studied how the change in 
shape of RBCs following along the path of the echinocytic transformation affects perfusion of an 
artificial microvascular network (AMVN).
STUDY DESIGN AND METHODS—Blood samples were obtained from healthy consenting 
volunteers. RBCs were leukocyte-reduced, re-suspended in saline, and treated with various 
concentrations of sodium salicylate to induce shape changes approximating the stages of 
echinocytosis experienced by RBCs during hypothermic storage (e.g. discocyte, echinocyte I, 
echinocyte II, echinocyte III, sphero-echinocyte and spherocyte). The AMVN perfusion rate was 
measured for 40% hematocrit suspensions of RBCs with different shapes.
RESULTS—The AMVN perfusion rates for RBCs with discocyte and echinocyte I shapes were 
similar, but there was a statistically significant decline in the AMVN perfusion rate between RBCs 
with shapes approximating each subsequent stage of echinocytosis. The difference in AMVN 
perfusion between discocytes and spherocytes (the last stage of the echinocytic transformation) 
was 34%.
CONCLUSION—The change in shape of RBCs from normal discocytes progressively through 
various stages of echinocytosis to spherocytes produced a substantial decline in the ability of these 
cells to perfuse an artificial microvascular network. Echinocytosis induced by hypothermic storage 
could therefore be responsible for a similarly substantial impairment of deformability previously 
observed for stored RBCs.
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Introduction
Under resting conditions, the human red blood cell (RBC) assumes the shape of a biconcave 
disc, called discocyte. This unique shape is explained by a state of least total curvature (and 
thus minimum bending energy) of RBC membrane.1 The RBC membrane consists of a lipid 
bilayer with a spectrin-based membrane cytoskeleton underneath. When either the structural 
properties of the cytoskeleton or the equilibrium between the two hemi-leaflets of the lipid 
bilayer are disturbed, the normal discocyte morphology is lost.2 Genetic defects with 
membrane protein abnormalities lead to spherocytosis or elliptocytosis.3 Disturbances in the 
lipid bilayer lead to stomatocytosis when the inner half of the bilayer is expanded relative to 
the outer half, and to echinocytosis or RBC crenation when the outer half is expanded 
relative to the inner half.4 Lipid bilayer disturbances may occur when certain molecules or 
drugs intercalate either into the inner or outer hemi-leaflet.1
The most common type of RBC shape transformation is echinocytosis, which has been 
observed under various circumstances in vitro and in vivo. Certain drugs may induce 
echinocytosis: radiocontrast media,5,6 propofol,7 fish oil,8 5-fluorouracil,9 antiepileptic 
drugs,10,11 non-steroidal anti-inflammatory drugs12 and particularly sodium-salicylate (SA), 
which has been used extensively to study echinocytosis in vitro.13-15 Hemodialysis16 and 
extracorporeal circulation during open heart surgery17 induce some degree of echinocytosis 
as well. Perhaps the most important instance of echinocytosis occurs during hypothermic 
storage of RBCs.18-20 The morphology of stored RBCs progressively deteriorates due to 
oxidative damage, biochemical changes and microvesiculation.21-25 Microvesiculation 
results in a disproportionately larger loss of cell membrane than cell volume, increasing 
sphericity of the cell. Stored RBCs gradually transition from normal, biconcave discocytes, 
through distinct intermediate echinocytic stages (echinocyte I, echinocyte II, echinocyte III, 
sphero-echinocyte) to spherocytes and ultimately undergo lysis.26 The rate and degree of 
this morphological deterioration varies greatly between individual RBCs, resulting in a 
highly heterogeneous population of cells with different morphologies within each stored 
RBC unit.
It is well known that hypothermic storage impairs RBC deformability, as evidenced by the 
increasing suspension viscosities19,20 as well as decreasing ability of stored RBCs to perfuse 
an artificial microvascular network.20 It is however not yet known whether RBC shape 
directly and independently affects microvascular perfusion. In this study we investigated the 
impact of various degrees of echinocytosis (induced by increasing concentrations of sodium 
salicylate) on perfusion of an artificial microvascular network (AMVN).
Materials and Methods
Device Preparation
A master silicon wafer containing the pattern of the AMVN device was fabricated using soft 
lithography as described previously.27-30 The AMVN device consisted of three parallel 
identical microchannel networks, each with a separate domed inlet port and all converging to 
the same domed outlet port.27 The AMVN comprised a system of microchannels with a 
depth of 5 μm and range of widths from 5 μm to 70 μm connected in a pattern inspired by 
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the layout of the microvasculature of rat mesentery.30 Polydimethylsiloxane (PDMS, 
Sylgard 184, Dow Corning Corp., Midland, MI) was poured over the wafer and cured at 
65°C for 3 hours to create a cast of the device. Biopsy punches (Acuderm, Inc., Fort 
Lauderdale, FL) were used to create access ports for the inlets (4 mm) and outlet (1.5 mm) 
through the PDMS cast. The AMVN device and a glass slide (VWR, West Chester, PA) 
spin-coated with a ~50 μm layer of PDMS were then plasma oxidized (100 seconds, air 
plasma) and bonded to one another. The assembled devices were filled with a 1% solution of 
mPEG-silane (Laysan Bio, Inc., Arab, AL) in GASP buffer (1.3 mM NaH2PO4, 9 mM 
Na2HPO4, 140 mM NaCl, 5.5 mM glucose, 1% bovine serum albumin; osmolality 290 
mmol/kg; pH 7.4)27 and incubated at ambient temperature for at least 8 hours to prevent cell 
adhesion to the walls of the microchannels. The mPEG-silane solution was flushed from the 
microchannel with GASP buffer prior to performing experiments.
Sample Preparation
Whole blood was collected from healthy consenting volunteers (n = 5) via venipuncture into 
Vacutainer tubes containing K2EDTA anticoagulant (BD, Franklin Lakes, NJ). Blood 
samples were leukoreduced using a high-efficiency pediatric leukocyte reduction filter 
(Purecell NEO, Pall Corp., Port Washington, USA).29 Samples were adjusted to 40% 
hematocrit (Hct) with normal saline (osmolality 290 mOsm/kg). To create RBC samples 
with various induced morphologies, 1 mL aliquots of leukoreduced, 40% Hct samples were 
centrifuged at 2500 × g for 5 minutes at ambient temperature (Microfuge 22R, Beckman 
Coulter, Fullerton, CA) to separate RBCs from the supernatant. Various volumes of 
supernatant were removed from the aliquoted samples and replaced with equal amounts of 
an isotonic stock solution of sodium salicylate (SA) in saline (290 mOsm/kg), to create 
solutions with final SA concentrations of 0, 9, 18, 27, 36 and 54 mM.14 The samples were 
mixed by inversion on a sample tube rotator (Labquake, Barnstead Thermolyne, Dubuque, 
IA) for 30 minutes prior to use. For each sample, RBC count and mean corpuscular 
hemoglobin (MCH) were measured with a hematology analyzer (Medonic M-series, Boule 
Medical AB, Stockholm, Sweden). Hct was measured from the relative fractions of packed 
RBCs and plasma in untreated plastic 75 mm microcapillary tubes (n = 4; Fisherbrand, 
Thermo Fisher Scientific, Waltham, MA) centrifuged for 15 minutes at 11,500 × g in a 
micro-hematocrit centrifuge (PowerSpin BX, UNICO, Princeton, NJ). Hct, measured by 
microcentrifugation, was used to calculate mean corpuscular volume, MCV = Hct × 10/RBC 
count. This calculated MCV was then used to calculate mean corpuscular hemoglobin 
concentration, MCHC = 100 × MCH/MCV.
Imaging and Analysis
An inverted bright-field microscope (IX71, Olympus America Inc., Center Valley, PA, USA) 
equipped with a high-speed camera (MC1362, Mikrotron GmbH, Unterschleissheim, 
Germany) was used to acquire images of the post-AMVN (venous) channels at 20x 
magnification. A band-pass blue-violet filter (394 ± 50 nm, B-390, Hoya Corp. USA, 
Fremont, CA) was placed between the microscope lamp and condenser in order to improve 
contrast (RBCs appear dark in blue light). A custom image capture application implemented 
in Microsoft Visual Studio (Microsoft Corp., Redmond, WA) was used to capture bursts of 
10 frames at 100 fps every 10 seconds for the duration of 5 minutes. A custom image 
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analysis algorithm implemented in MATLAB (The Math Works Inc., Natick, MA, USA) 
was used to analyze the image sequences and calculate the RBC velocity (VRBC; μm/s) in 
the channels at each time point based on the shift in RBC position between images. 
Perfusion rate was defined as the product of the cross sectional area of the post-AMVN 
microchannel (Achannel; 350 μm2) and the measured RBC velocity (perfusion rate = VRBC × 
Achannel; μm3/s = 1 × 10−6 nL/s). For each sample, the perfusion rate was normalized with 
respect to the perfusion rate of a control sample (normal, untreated RBCs) run through the 
same device.
Experimental Setup
Figure 1 demonstrates the components of the AMVN measurement system. A water 
reservoir fixed to a vertical linear motion stage (Series A40 UniSlides, Velmex Inc., 
Bloomfield, NY) connected with flexible plastic tubing (Tygon R-3603, VWR, West 
Chester, PA) and a barbed tube fitting (L420/410-6, Value Plastics, Fort Collins, CO) to the 
outlet of the AMVN device (Figure 1a,b), was used to control the driving pressure of the 
system by adjusting hydrostatic pressure between the AMVN inlets and the reservoir.29,30 
The microscope field-of-view was then aligned with the post-AMVN venule microchannels 
and a best-effort manual focusing was performed using the walls of the microchannels as 
high-contrast standard. To perform the measurement, GASP buffer was removed from the 
inlets of the AMVN device and 25 μL of RBC sample was deposited in each inlet. The 
system driving pressure was then set to approximately −10 cmH2O and the RBCs were 
allowed to perfuse the system until RBCs from all three inlets reached the outlet port. The 
water column was then adjusted such that flow through the device stopped (0 cmH2O 
driving pressure) and the image capture application was initiated. A baseline perfusion rate 
(~0 nL/s) was established for 30 seconds, and then the driving pressure was set to −20 
cmH2O for the remainder of the 5 minute image capture period.
The AMVN device consisted of three identical networks of microchannels, each with their 
own inlet port, converging to the same outlet port (Fig. 1c). Three samples (two 
experimental and one control) were run in parallel through identical networks within each 
device. The variation in AMVN perfusion rate between microchannels within a single device 
is <1%, and the variation between microchannels in different devices is <2%, as previously 
shown.27 Samples treated with appropriate concentration of SA to induce each distinct RBC 
morphology were run in multiple channels within a single device, and in multiple separate 
devices to minimize potential bias due to minor fabrication irregularities.
Statistical Analysis
Statistical analysis was performed using built-in functions of MATLAB 2014b Statistics 
Toolbox (The Math Works Inc, Natick, MA). A paired t-test was used for the comparison 
between two groups. The results are presented as mean values ± standard deviation. A p-
value of < 0.01 was considered statistically significant.
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Results
Figure 2 illustrates the changes in RBC morphology induced by exposure to different SA 
concentrations. The specific concentrations of SA were chosen so that the resulting 
morphologies approximated different degrees of echinocytosis,26,31 namely: echinocyte I (an 
irregularly contoured discocyte with up to 5 protrusions) for 9 mM SA; echinocyte II (a flat 
RBC with a few spicules) for 18 mM SA; echinocyte III (an ovaloid or spherical RBC with 
many spicules) for 27 mM SA; sphero-echinocyte (a spherical RBC with multiple short and 
thin spicules) for 36 mM SA; and finally spherocyte (a completely spherical RBC) for 54 
mM SA.
Figure 3 shows the characteristic images of RBCs (Fig. 3b) with each of the induced 
morphologies as they perfused the arteriole and capillary portions of the AMVN (Fig. 3a). 
Our visual phenomenological observations showed that morphology of RBCs influenced 
their flow, packing and deformation characteristics within the AMVN. Echinocytic RBCs 
were unable to form the characteristic bullet shapes as they traversed microcapillaries (Fig. 
3b). The spherical geometry of sphero-echinocytes and spherocytes severely limited the 
number of RBCs which could simultaneously pass through individual microchannels (Fig. 
3b).
Figure 4 shows the normalized AMVN perfusion rates for RBCs with different shapes. For 
each trial, a control, untreated RBC sample (0 mM SA; Hct = 39.6 ± 0.8 %; MCV = 85.6 
± 1.7 fL; MCHC = 32.2 ± 0.6 g/dL) and two experimental, treated RBC samples were 
analyzed using the three identical channels comprising each AMVN device. RBC samples 
from each of the five volunteers were used to evaluate each SA concentration independently 
(50 experiments for untreated samples, 0 mM; n = 19 experiments for each of the samples 
exposed to 9, 18, 27, 36, and 54 mM of sodium salicylate). The AMVN perfusion rate 
decreased as the degree of echinocytosis increased. There was only a minor, non-significant 
decrease in perfusion rate from discocyte to induced echinocyte I (0.1% of discocyte; p = 
0.837). The perfusion rate then drastically decreased from echinocyte I to echinocyte II 
(8.8% of discocyte; p = 0.0000414), more so from echinocyte II to echinocyte III (15.9% of 
discocyte; p = 0.00000000495), and even further from echinocyte III to sphero-echinocyte 
(5.8% of discocyte; p = 0.000580). The decrease in the AMVN perfusion rate from sphero-
echinocyte to spherocyte (3.0% of discocyte; p = 0.00690) was noticeable but less drastic. 
Overall, there was a decrease in the AMVN perfusion rate of 33.6% as the RBC shape 
progressively changed from discocyte to spherocyte (Fig. 4). For context, a previous study 
found that the overall decrease in AMVN perfusion rate for hypothermically stored RBC 
units between week 0 and week 6 of storage is approximately 20 – 25%.20,27
We found that exposure to SA resulted in small decrease of MCV (up to 5.2 fL) and a 
modest increase of MCHC (up to 2.0 g/dL) compared to normal discocytes (Table 1), which 
is in agreement with earlier observations.14 The decrease in MCV (1.7% of discocyte; p = 
0.252) and increase in MCHC (5.0% of discocyte; p = 0.0105) between discocytes (0 mM 
SA) and induced spherocytes (54 mM SA) were not statistically significant. The decrease in 
Hct between discocytes and induced spherocytes, potentially due to lysis, was statistically 
significant (5.7% of discocyte; p = 0.00499). For all of our samples, MCHC ranged from 
Piety et al. Page 5
Transfusion. Author manuscript; available in PMC 2017 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
32.0 to 34.0 g/dL, and the maximum decrease in AMVN perfusion rate was 0.084 nL/s (or 
33.6% of the perfusion rate for discocytes). We have previously shown that changes in 
MCHC of up to 7.8 g/dL produce a decrease in the AMVN perfusion rate of <0.016 nL/s (or 
6.6% of discocyte).32 The decreases in AMVN perfusion rate experienced by induced 
echinocyte II (9.0% of discocyte), echinocyte III (24.9% of discocyte), sphero-echinocytes 
(30.6% of discocyte) and spherocytes (33.6% of discocyte) were all significantly greater 
than would be expected based on change in MCHC alone.
Discussion
SA produced a concentration-dependent echinocytic shape transformation comparable to 
earlier studies.13-15,33-35 The influence of SA-induced echinocytosis on rheological 
parameters has been extensively studied in the past. RBC suspension viscosity is increased, 
due to mechanical hindrance between spiculated RBCs.13,14,34 RBC aggregation is 
drastically reduced because spiculated RBCs are unable to make large enough surface area 
contact with neighboring cells to form stable aggregates.33,34 The passage of narrow filter 
pores with a nominal diameter of 3μm (i.e. smaller than the diameter of the smallest 
capillary in our AMVN device) was not hindered, but even facilitated by SA-induced 
echinocytosis of higher degree, explained by a preserved or even increased surface area to 
volume ratio of echinocytes, which is the most relevant parameter for the passage of very 
narrow pores.14 On the level of membrane deformability, micropipette experiments have 
shown that echinocytes induced by SA had a slightly increased resistance to membrane 
extension.35 Shape normalization by the addition of a counteracting stomatocytogenic agent 
such as chlorpromazine normalized these rheological alterations, indicating that the shape 
matters and not the drug interaction with the RBC membrane itself.34,35 Taken together, 
these divergent rheological results make it difficult to anticipate the role of the RBC shape in 
microvascular perfusion, which is most important in (patho)physiological and clinical terms 
and has prompted the present study.
We found that perfusion of the artificial microvascular network (AMVN) was maximized for 
RBCs of normal biconcave discoid and echinocyte I shape. These results suggest that 
although discocytes are best for microvascular perfusion, some degree of RBC shape 
deterioration such as the initial stages of echinocytosis could be well-tolerated by the 
microvasculature. Further progression of RBCs along the path of the echinocytic 
transformation towards spherocytosis gradually decreased the AMVN perfusion in our 
experiments. The maximum average drop of the AMVN perfusion rate we measured in this 
study was approximately 30% for the sample that mostly consisted of spherocytes (the end 
point of the echinocytic transformation). Echinocytosis is by far the most common type of 
RBC shape deterioration occurring during hypothermic storage,26 and therefore our results 
could have particularly important implications in the context of blood storage and 
transfusion. Interestingly, in our previous studies we measured a 20-25% difference in the 
AMVN perfusion rate between fresh RBC (mostly discocytes) and RBC stored 
hypothermically for 6 weeks.20,27 Because 6-week old blood is a heterogeneous mixture 
composed predominantly of cells in early stages of echinocytosis (which may recover their 
shape in vivo, post-transfusion36 or via washing20), some discocytes and a sizable fraction of 
irreparably damaged late stage echinocytes and spherocytes,26 the shape change could 
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explain a large fraction of the decline in the AMVN perfusion rate we have previously 
measured for hypothermically stored blood.
During flow in the circulation, RBCs are exposed to a large variety of shear stresses, ranging 
from very small, such as in the axis of a large vessel, where the shear stress approaches zero, 
to very large shear stresses, such as in capillaries, where the strongest RBC deformation 
occurs. The deformation into a bullet-like shape in smaller capillaries is only possible 
because RBCs have a high surface area to volume ratio, which is a geometric prerequisite 
for this deformation.37 When the surface area to volume ratio is decreased (i.e. RBCs 
become more spherical as seen in hypotonic swelling) RBC deformability in capillaries is 
reduced, which reduces the AMVN perfusion rate.32 The present data and earlier 
observations14 indicate that echinocytosis induced by SA does not decrease the surface area 
to volume ratio of RBCs, thus allowing an unhindered passage of smallest capillaries (5 μm) 
within the AMVN (or even narrower channels such as 3 μm filter pores14) despite the fact 
that echinocytes have an increased resistance to membrane deformation as measured by the 
micropipette aspiration technique,35 and an increased suspension viscosity due to the 
entanglement among spiculated RBCs.14,19 We conclude, therefore, that the decrease in the 
ability of echinocytic RBCs to perfuse the AMVN was not caused by a deformability-
dependent reduced capacity of single RBCs to pass through the smallest capillaries, but was 
caused primarily by an impaired flow in arteriole/venule-sized channels (13-70 μm).
Our present data suggest that deterioration of RBC shape occurring during hypothermic 
storage is likely a significant cause of the storage-induced decline of RBC deformability, 
particularly as reflected by a reduction in the ability of stored RBCs to perfuse an artificial 
microvascular network. It has been shown that RBC units stored for less than 2 weeks (and 
therefore containing on average less echinocytes19) decrease post-transfusion morbidity and 
mortality in patients undergoing cardiac surgery,38,39 which has, however, not been 
confirmed by a more recent study.40 Our data suggest that the degree of storage-induced 
echinocytosis in each particular RBC unit could influence microcirculatory blood flow in 
vivo and thus contribute to different clinical outcomes.41 We had previously shown that 
severe echinocytosis after prolonged hypothermic storage can be partially reversed towards 
discocytosis by washing stored RBCs in a 1% human serum albumin (HSA) solution, a 
procedure that also significantly improves the ability of stored RBCs to perfuse the 
AMVN.20 We reason therefore that if the echinocytic transformation of RBC shape due to 
hypothermic storage could be either completely prevented, or arrested in its earliest stages 
(e.g. echinocyte I), or reversed through some kind of treatment right before transfusion (e.g. 
washing in 1% HSA) the microvascular perfusion in the recipient may be improved.
Our results may have important implications in other clinically-relevant contexts. For 
example, it is well-known that radiographic contrast media may induce echinocytosis in 
vivo.42 Angiography (e.g. of the brain, heart, or leg) may induce echinocytosis, which could, 
at least temporarily, reduce microvascular perfusion and by doing so deteriorate critical 
peripheral ischemia further. It is, therefore, advisable to use the smallest possible volume of 
contrast medium and choose one with low echinocytogenic properties.5,42 Although our 
results cannot be easily generalized for other, similar shape abnormalities (e.g. 
acanthocytosis43,44), it is very likely that they might be disadvantageous as well.
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We conclude that normal discocytes represent the optimum RBC shape for AMVN perfusion 
and that the echinocytic shape transformation leads to a progressive decrease of AMVN 
perfusion rates. RBC shape is an indicator of the rheological performance of RBCs in the 
microvasculature and therefore could be used as a measure of the quality of stored blood 
units.
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Fig. 1. 
Representative images of RBCs treated with various concentrations of sodium salicylate 
(SA). Exposure to SA changed the shape of RBCs in a dose-dependent fashion, 
approximating the increasing degrees of echinocytosis (0 mM – discocyte; 9 mM – 
echinocyte I; 18 mM – echinocyte II; 27 mM – echinocyte III; 36 mM – sphero-echinocyte, 
54 mM – spherocyte). Scale bar is 10 μm.
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Fig. 2. 
Setup for measuring the AMVN perfusion rate. (a) Complete AMVN system. (b) A 
reservoir attached to the vertical linear motion stage is used to control the driving pressure of 
the AMVN system. The AMVN device is connected to the reservoir by a length of plastic 
tubing through a barbed tube fitting. (c) Photograph of the AMVN device loaded with an 
RBC sample (one-cent U.S. coin is shown for size reference).
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Fig. 3. 
The flow patterns of blood samples with RBCs of different shapes in the AMVN. (a) Bright-
field micrograph of the three parallel microvascular network units of the AMVN device 
containing RBCs (arrow indicates direction of flow, scale bar is 100 μm). (b) Bright-field 
micrographs of RBCs exposed to various concentrations of sodium salicylate as they perfuse 
portions of the AMVN: (upper row) 70 μm AMVN arteriole microchannel; (lower row) 10 
μm capillary microchannel splitting into a 5 μm and a 15 μm capillary microchannels (arrow 
indicates direction of flow, scale bar is 10 μm).
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Fig. 4. 
The dependence of the AMVN perfusion rate on RBC shape. Inset images show (from left to 
right) a discocyte, an echinocyte I, an echinocyte II, an echinocyte III, a sphero-echinocyte, 
and a spherocyte. Perfusion rates were normalized with respect to the perfusion rate of 
normal RBCs (discocytes; 0 mM SA). Mean values ± standard deviation; 50 experiments for 
untreated samples, 0 mM; 19 experiments for each of the samples exposed to 9, 18, 27, 36, 
and 54 mM of sodium salicylate. The p-values indicate the statistical significance of the 
change in mean AMVN perfusion rate between the bracketed RBC shapes (asterisk denotes 
a significant change).
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Table 1
Summary of hemorheological parameters at different sodium salicylate concentrations (mean values ± 
standard deviation, n = 5). Hct was measured by microcentrifugation. RBC number was measured by 
hematology analyzer. Mean corpuscular volume was calculated as MCV = Hct × 10/RBC count, where RBC 
count was measured by hematology analyzer. Mean corpuscular hemoglobin concentration was calculated as 
MCHC = 100 × MCH/MCV, where MCH (mean corpuscular hemoglobin) was measured by hematology 
analyzer. Measured non-normalized AMVN perfusion rate (mean values ± standard deviation; 50 experiments 
for untreated samples, 0 mM; 19 experiments for each of the samples exposed to 9, 18, 27, 36, and 54 mM of 
sodium salicylate).
Sodium salicylate concentration (mM)
0 9 18 27 36 54
Hct (%) 39.6 ± 0.8 39.7 ± 0.9 38.9 ± 0.3 39.0 ± 0.6 38.8 ± 0.6 37.4 ± 0.5
RBC count (1012/L) 4.63 ± 0.00 4.58 ± 0.00 4.63 ± 0.00 4.79 ± 0.00 4.64 ± 0.00 4.44 ± 0.00
MCV (fL) 85.6 ± 1.7 86.6 ± 2.0 84.0 ± 0.7 81.4 ± 1.3 83.7 ± 1.4 84.2 ± 1.0
MCHC (g/dL) 32.2 ± 0.6 32.0 ± 0.7 33.0 ± 0.3 34.0 ± 0.5 33.8 ± 0.5 33.9 ± 0.4
AMVN perfusion
rate (nL/s) 0.268 ± 0.022 0.261 ± 0.025 0.237 ± 0.021 0.198 ± 0.012 0.187 ± 0.011 0.182 ± 0.012
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